Arrest TB

Arrest TB plans to deliver low-cost, portable and easy-to-use tests for TB presence and drug-resistance.

07899774740
sesha.venkateswaran@ed.ac.uk
University of Edinburgh, King’s Buildings, Edinburgh

Recent Posts
Image Alt

News

On the 28th of October,  members of the ARREST TB project used a game of Tuberculosis Tag developed for the Explorathon events at Heriot-Watt by Dr Helen Bridle to educate science enthusiasts of all ages on the threat of multi-drug resistance tuberculosis, how it spreads and how it comes about.  People of all ages discovered the importance of improving diagnostic technology in tackling this problem.

ARREST TB members, led by Dr Helen Bridle will be hosting an event for Explorathon 2019 at the Lyell Centre on the Heriot-Watt University campus on the 28th of September 2019. The event is free but attendees are encouraged to book tickets in advance for one of our exciting 30 minute games, where children will be encourage to see if they can outrun a tuberculosis infection, what medicine is

Edinburgh played host to the latest meeting of the ARREST TB project. Attendees from research institutes, universities, and companies across Europe, Russia, and India presented their work over two days, with significant progress demonstrated by all. The next meeting is expected to be held in January in Russia.

Two members of the ARREST-TB consortium, the University of Edinburgh, School of Chemistry and the National Institute for Research in Tuberculosis (NIRT), India, along with other leading Indian and UK institutes held a workshop titled "Multi-disciplinary workshop – Achieving rapid, accurate and affordable diagnosis of tuberculosis and drug-resistant tuberculosis in minimally resourced settings"  in Chennai, India between June 3rd to 6th. The workshop was supported by a Researcher Links

The members of the ARREST TB project came together for their biannual team meeting to share their progress and plan for the following six months. The meeting was hosted by the National Institute for Research in Tuberculosis in Chennai, India on the 9th and 10th of June. Robust discussions were held over two days, covering all work packages, with the project on track to deliver the various diagnostic technologies for